2
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Pancreatic Neoplasms
154
Breast Neoplasms
117
Carcinoma, Non-Small-Cell Lung
66
Triple Negative Breast Neoplasms
45
Neoplasm Metastasis
45
Neoplasms
44
Lung Neoplasms
26
Ovarian Neoplasms
25
Squamous Cell Carcinoma of Head and Neck
24
Stomach Neoplasms
23
Melanoma
16
Esophageal Neoplasms
16
Adenocarcinoma
15
Head and Neck Neoplasms
13
Recurrence
12
Esophageal Squamous Cell Carcinoma
12
Cholangiocarcinoma
12
Sarcoma
11
Parkinson Disease 4, Autosomal Dominant Lewy Body
11
Small Cell Lung Carcinoma
10
Fallopian Tube Neoplasms
10
Uterine Cervical Neoplasms
9
Urinary Bladder Neoplasms
8
Pancreatic Adenocarcinoma
8
Colorectal Neoplasms
8
Prostatic Neoplasms
7
Inflammatory Breast Neoplasms
7
Carcinoma, Pancreatic Ductal
7
Breast Neoplasms, Male
7
Biliary Tract Neoplasms
7
Interventions
Temozolomide
405
Radiotherapy
202
Bevacizumab
157
Radiation
80
Magnetic Resonance Spectroscopy
77
Lomustine
49
Surgical Procedures, Operative
45
Carmustine
41
pembrolizumab
40
Irinotecan
38
Nivolumab
32
Specimen Handling
28
Carboplatin
27
Radiosurgery
24
Erlotinib Hydrochloride
24
Drug Therapy
23
Chemotherapy, Adjuvant
23
Radiotherapy, Intensity-Modulated
22
Cyclophosphamide
20
Aminolevulinic Acid
20
O(6)-benzylguanine
17
sargramostim
16
Radiotherapy, Conformal
15
Blood Specimen Collection
15
temsirolimus
14
Granulocyte-Macrophage Colony-Stimulating Factor
14
Everolimus
14
Vorinostat
13
Sorafenib
13
Ipilimumab
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Glioblastoma
×
Albumin-Bound Paclitaxel
×
Clear all
NCT04528680
2026-04-13
SC9/ABX
Northwestern University
Phase 1/2
Active not recruiting
57 enrolled